| 000 | 01481 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514002002.0 | ||
| 264 | 0 | _c20011101 | |
| 008 | 200111s 0 0 eng d | ||
| 022 | _a0923-7534 | ||
| 024 | 7 |
_a10.1023/a:1011139918558 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSteele, J P | |
| 245 | 0 | 0 |
_aPhase II trial of liposomal daunorubicin in malignant pleural mesothelioma. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cApr 2001 |
||
| 300 |
_a497-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aDaunorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLiposomes |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesothelioma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPleural Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aO'Doherty, C A | |
| 700 | 1 | _aShamash, J | |
| 700 | 1 | _aEvans, M T | |
| 700 | 1 | _aGower, N H | |
| 700 | 1 | _aTischkowitz, M D | |
| 700 | 1 | _aRudd, R M | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 12 _gno. 4 _gp. 497-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1011139918558 _zAvailable from publisher's website |
| 999 |
_c11329405 _d11329405 |
||